General Information of the Compound
| Compound ID |
CP0466304
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[2-(cyclopropanecarbonylamino)pyridin-4-yl]-4-[2-[2-[2-[2-[4-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxymethyl]triazol-1-yl]ethoxy]ethoxy]ethoxy]ethoxy]-N-methyl-1,3-thiazole-5-carboxamide
Show/Hide
|
||||||||||||||||||
| Formula |
C38H41N9O11S
|
||||||||||||||||||
| Molecular Weight |
831.865
|
||||||||||||||||||
| Canonical SMILES |
CNC(=O)c1sc(nc1OCCOCCOCCOCCn1cc(COc2cccc3C(=O)N(C4CCC(=O)NC4=O)C(=O)c23)nn1)-c1ccnc(NC(=O)C2CC2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H41N9O11S/c1-39-34(51)31-35(43-36(59-31)23-9-10-40-28(19-23)41-32(49)22-5-6-22)57-18-17-56-16-15-55-14-13-54-12-11-46-20-24(44-45-46)21-58-27-4-2-3-25-30(27)38(53)47(37(25)52)26-7-8-29(48)42-33(26)50/h2-4,9-10,19-20,22,26H,5-8,11-18,21H2,1H3,(H,39,51)(H,40,41,49)(H,42,48,50)
Show/Hide
|
||||||||||||||||||
| InChIKey |
FEICDSOLEYDNQO-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound